組換えタンパク質の世界市場2023年~2027年

◆英語タイトル:Global Recombinant Proteins Market 2023-2027

Technavioが発行した調査報告書(IRTNTR74151-23)◆商品コード:IRTNTR74151-23
◆発行会社(リサーチ会社):Technavio
◆発行日:2023年4月19日
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

テックナビオインフィニティリサーチ社は、世界の組換えタンパク質市場規模が予測期間中(2022年~2027年)にCAGR 9.46%増加し、650.96百万ドルまで拡大すると予測しています。本書では、組換えタンパク質の世界市場を対象に調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、用途別(バイオテクノロジー研究、創薬・医薬品開発、バイオ医薬品の生産、その他)分析、エンドユーザー別(製薬・バイオテクノロジー企業、学術・研究機関、その他)分析、顧客状況、地域別(北米、ヨーロッパ、アジア、その他地域、アメリカ、中国、ドイツ、イタリア、日本)分析、成長要因・課題・動向、企業状況、企業分析などの項目を掲載しています。なお、市場調査の対象になる企業情報には、Abcam plc、Airway Therapeutics Inc.、Amgen Inc.、Aviva Systems Biology Corp.、Bio Techne Corp.、Bio Rad Laboratories Inc.、BPS Bioscience Inc.、Elabscience Biotechnology Inc.、Enzo Biochem Inc.、GenScript Biotech Corp.などが含まれております。
・エグゼクティブサマリー
・市場状況
・市場規模・予測
・過去の市場規模
・ファイブフォース分析
・世界の組換えタンパク質市場規模:用途別
- バイオテクノロジー研究における市場規模
- 創薬・医薬品開発における市場規模
- バイオ医薬品の生産における市場規模
- その他用途における市場規模
・世界の組換えタンパク質市場規模:エンドユーザー別
- 製薬・バイオテクノロジー企業における市場規模
- 学術・研究機関における市場規模
- その他エンドユーザーにおける市場規模
・顧客状況
・世界の組換えタンパク質市場規模:地域別
- 北米の組換えタンパク質市場規模
- ヨーロッパの組換えタンパク質市場規模
- アジアの組換えタンパク質市場規模
- その他地域の組換えタンパク質市場規模
- アメリカの組換えタンパク質市場規模
- 中国の組換えタンパク質市場規模
- ドイツの組換えタンパク質市場規模
- イタリアの組換えタンパク質市場規模
- 日本の組換えタンパク質市場規模
・成長要因・課題・動向
・企業状況
・企業分析

テックナビオインフィニティリサーチ社は、利益・価格・競争・プロモーションなどの主なパラメーターの分析や、多数の情報源からの情報を調査・統合・総括することによって、組換えタンパク質市場の細部にわたる実態を提供します。また、市場の主要インフルエンサーを明らかにすることで、市場の多様な面を提示します。提示された情報は総合的で信頼度が高く、一次・二次の広範囲に行った調査の結果です。 テックナビオインフィニティリサーチ社の市場調査書は、的確な組換えタンパク質市場の拡大を推測するために、質的・量的調査を用いた完全な競争状況・詳細なベンダー選択手法・分析を提供します。

組換えタンパク質の世界市場 2023-2027

Technavio社は、組換えタンパク質市場をモニターしており、2022年から2027年にかけて650.96百万米ドルの成長が予測され、予測期間中のCAGRは9.46%で加速すると予測しています。

当レポートでは、組換えタンパク質市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、慢性疾患の増加、生物製剤とバイオシミラーへの傾斜の高まり、組換えタンパク質の生産における技術的進歩が牽引しています。

Technavioの組換えタンパク質市場は以下のようにセグメント化されています:

・用途別:
– バイオテクノロジー研究
– 創薬・医薬品開発
– バイオ医薬品製造
– その他

・エンドユーザー別:
– 製薬・バイオテクノロジー企業
– 学術・研究機関
– その他

・地域別:
– 北米
– ヨーロッパ
– アジア
– その他の地域(ROW)

本調査では、今後数年間の組換えタンパク質市場の成長を促進する主な理由の一つとして、ベンダーによる共同研究や戦略的提携の増加を挙げています。また、R&Dへの支出の増加や新興国からのビジネスチャンスの拡大は、市場の大きな需要につながるでしょう。

Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

当レポートでは、組換えタンパク質市場について以下の分野をカバーしています:
– 組換えタンパク質市場のサイジング
– 組換えタンパク質市場の予測
– 組換えタンパク質市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Abcam plc, Airway Therapeutics Inc., Amgen Inc., Aviva Systems Biology Corp., Bio Techne Corp., Bio Rad Laboratories Inc., BPS Bioscience Inc., Elabscience Biotechnology Inc., Enzo Biochem Inc., GenScript Biotech Corp., Grifols SA, Merck KGaA, Novartis AG, Novo Nordisk AS, OriGene Technologies Inc., Prospec Tany Technogene Ltd., Proteintech Group Inc., Sanofi SA, Sino Biological Inc., and Thermo Fisher Scientific Inc.などの企業情報が含まれています。また、組換えタンパク質市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。

Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global recombinant proteins market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global recombinant proteins market 2017 – 2021 ($ million)
o 4.2 Application Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Application Segment 2017 – 2021 ($ million)
o 4.3 End-user Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application – Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Biotechnology research – Market size and forecast 2022-2027
o Exhibit 34: Chart on Biotechnology research – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Biotechnology research – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Biotechnology research – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Biotechnology research – Year-over-year growth 2022-2027 (%)
o 6.4 Drug discovery and development – Market size and forecast 2022-2027
o Exhibit 38: Chart on Drug discovery and development – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Drug discovery and development – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Drug discovery and development – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Drug discovery and development – Year-over-year growth 2022-2027 (%)
o 6.5 Biopharmaceutical production – Market size and forecast 2022-2027
o Exhibit 42: Chart on Biopharmaceutical production – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Biopharmaceutical production – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Biopharmaceutical production – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Biopharmaceutical production – Year-over-year growth 2022-2027 (%)
o 6.6 Others – Market size and forecast 2022-2027
o Exhibit 46: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Application
o Exhibit 50: Market opportunity by Application ($ million)
o Exhibit 51: Data Table on Market opportunity by Application ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 52: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 53: Data Table on End-user – Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 54: Chart on Comparison by End-user
o Exhibit 55: Data Table on Comparison by End-user
o 7.3 Pharma and biotechnology companies – Market size and forecast 2022-2027
o Exhibit 56: Chart on Pharma and biotechnology companies – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Pharma and biotechnology companies – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Pharma and biotechnology companies – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Pharma and biotechnology companies – Year-over-year growth 2022-2027 (%)
o 7.4 Academic and research institutes – Market size and forecast 2022-2027
o Exhibit 60: Chart on Academic and research institutes – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Academic and research institutes – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Academic and research institutes – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Academic and research institutes – Year-over-year growth 2022-2027 (%)
o 7.5 Others – Market size and forecast 2022-2027
o Exhibit 64: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by End-user
o Exhibit 68: Market opportunity by End-user ($ million)
o Exhibit 69: Data Table on Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 75: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 79: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 83: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 87: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 91: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 95: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 99: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 Italy – Market size and forecast 2022-2027
o Exhibit 103: Chart on Italy – Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on Italy – Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on Italy – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Italy – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 107: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 108: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ million)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 Abcam plc
o Exhibit 119: Abcam plc – Overview
o Exhibit 120: Abcam plc – Product / Service
o Exhibit 121: Abcam plc – Key news
o Exhibit 122: Abcam plc – Key offerings
o 12.4 Amgen Inc.
o Exhibit 123: Amgen Inc. – Overview
o Exhibit 124: Amgen Inc. – Product / Service
o Exhibit 125: Amgen Inc. – Key offerings
o 12.5 Aviva Systems Biology Corp.
o Exhibit 126: Aviva Systems Biology Corp. – Overview
o Exhibit 127: Aviva Systems Biology Corp. – Product / Service
o Exhibit 128: Aviva Systems Biology Corp. – Key offerings
o 12.6 Bio Rad Laboratories Inc.
o Exhibit 129: Bio Rad Laboratories Inc. – Overview
o Exhibit 130: Bio Rad Laboratories Inc. – Business segments
o Exhibit 131: Bio Rad Laboratories Inc. – Key news
o Exhibit 132: Bio Rad Laboratories Inc. – Key offerings
o Exhibit 133: Bio Rad Laboratories Inc. – Segment focus
o 12.7 BPS Bioscience Inc.
o Exhibit 134: BPS Bioscience Inc. – Overview
o Exhibit 135: BPS Bioscience Inc. – Product / Service
o Exhibit 136: BPS Bioscience Inc. – Key offerings
o 12.8 Enzo Biochem Inc.
o Exhibit 137: Enzo Biochem Inc. – Overview
o Exhibit 138: Enzo Biochem Inc. – Product / Service
o Exhibit 139: Enzo Biochem Inc. – Key offerings
o 12.9 GenScript Biotech Corp.
o Exhibit 140: GenScript Biotech Corp. – Overview
o Exhibit 141: GenScript Biotech Corp. – Business segments
o Exhibit 142: GenScript Biotech Corp. – Key news
o Exhibit 143: GenScript Biotech Corp. – Key offerings
o Exhibit 144: GenScript Biotech Corp. – Segment focus
o 12.10 Merck KGaA
o Exhibit 145: Merck KGaA – Overview
o Exhibit 146: Merck KGaA – Business segments
o Exhibit 147: Merck KGaA – Key news
o Exhibit 148: Merck KGaA – Key offerings
o Exhibit 149: Merck KGaA – Segment focus
o 12.11 Novartis AG
o Exhibit 150: Novartis AG – Overview
o Exhibit 151: Novartis AG – Business segments
o Exhibit 152: Novartis AG – Key offerings
o Exhibit 153: Novartis AG – Segment focus
o 12.12 Novo Nordisk AS
o Exhibit 154: Novo Nordisk AS – Overview
o Exhibit 155: Novo Nordisk AS – Business segments
o Exhibit 156: Novo Nordisk AS – Key offerings
o Exhibit 157: Novo Nordisk AS – Segment focus
o 12.13 Prospec Tany Technogene Ltd.
o Exhibit 158: Prospec Tany Technogene Ltd. – Overview
o Exhibit 159: Prospec Tany Technogene Ltd. – Product / Service
o Exhibit 160: Prospec Tany Technogene Ltd. – Key offerings
o 12.14 Proteintech Group Inc.
o Exhibit 161: Proteintech Group Inc. – Overview
o Exhibit 162: Proteintech Group Inc. – Product / Service
o Exhibit 163: Proteintech Group Inc. – Key offerings
o 12.15 Sanofi SA
o Exhibit 164: Sanofi SA – Overview
o Exhibit 165: Sanofi SA – Business segments
o Exhibit 166: Sanofi SA – Key news
o Exhibit 167: Sanofi SA – Key offerings
o Exhibit 168: Sanofi SA – Segment focus
o 12.16 Sino Biological Inc.
o Exhibit 169: Sino Biological Inc. – Overview
o Exhibit 170: Sino Biological Inc. – Product / Service
o Exhibit 171: Sino Biological Inc. – Key offerings
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 172: Thermo Fisher Scientific Inc. – Overview
o Exhibit 173: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 174: Thermo Fisher Scientific Inc. – Key news
o Exhibit 175: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 176: Thermo Fisher Scientific Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 177: Inclusions checklist
o Exhibit 178: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 179: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 180: Research methodology
o Exhibit 181: Validation techniques employed for market sizing
o Exhibit 182: Information sources
o 13.5 List of abbreviations
o Exhibit 183: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Application
Exhibits6: Executive Summary – Chart on Market Segmentation by End-user
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global recombinant proteins market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Application Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Application – Market share 2022-2027 (%)
Exhibits31: Data Table on Application – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Biotechnology research – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Biotechnology research – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Biotechnology research – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Biotechnology research – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Drug discovery and development – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Drug discovery and development – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Drug discovery and development – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Drug discovery and development – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Biopharmaceutical production – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Biopharmaceutical production – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Biopharmaceutical production – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Biopharmaceutical production – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Application ($ million)
Exhibits51: Data Table on Market opportunity by Application ($ million)
Exhibits52: Chart on End-user – Market share 2022-2027 (%)
Exhibits53: Data Table on End-user – Market share 2022-2027 (%)
Exhibits54: Chart on Comparison by End-user
Exhibits55: Data Table on Comparison by End-user
Exhibits56: Chart on Pharma and biotechnology companies – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Pharma and biotechnology companies – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Pharma and biotechnology companies – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Pharma and biotechnology companies – Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Academic and research institutes – Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Academic and research institutes – Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Academic and research institutes – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Academic and research institutes – Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits68: Market opportunity by End-user ($ million)
Exhibits69: Data Table on Market opportunity by End-user ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Italy – Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Italy – Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Italy – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Italy – Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Abcam plc – Overview
Exhibits120: Abcam plc – Product / Service
Exhibits121: Abcam plc – Key news
Exhibits122: Abcam plc – Key offerings
Exhibits123: Amgen Inc. – Overview
Exhibits124: Amgen Inc. – Product / Service
Exhibits125: Amgen Inc. – Key offerings
Exhibits126: Aviva Systems Biology Corp. – Overview
Exhibits127: Aviva Systems Biology Corp. – Product / Service
Exhibits128: Aviva Systems Biology Corp. – Key offerings
Exhibits129: Bio Rad Laboratories Inc. – Overview
Exhibits130: Bio Rad Laboratories Inc. – Business segments
Exhibits131: Bio Rad Laboratories Inc. – Key news
Exhibits132: Bio Rad Laboratories Inc. – Key offerings
Exhibits133: Bio Rad Laboratories Inc. – Segment focus
Exhibits134: BPS Bioscience Inc. – Overview
Exhibits135: BPS Bioscience Inc. – Product / Service
Exhibits136: BPS Bioscience Inc. – Key offerings
Exhibits137: Enzo Biochem Inc. – Overview
Exhibits138: Enzo Biochem Inc. – Product / Service
Exhibits139: Enzo Biochem Inc. – Key offerings
Exhibits140: GenScript Biotech Corp. – Overview
Exhibits141: GenScript Biotech Corp. – Business segments
Exhibits142: GenScript Biotech Corp. – Key news
Exhibits143: GenScript Biotech Corp. – Key offerings
Exhibits144: GenScript Biotech Corp. – Segment focus
Exhibits145: Merck KGaA – Overview
Exhibits146: Merck KGaA – Business segments
Exhibits147: Merck KGaA – Key news
Exhibits148: Merck KGaA – Key offerings
Exhibits149: Merck KGaA – Segment focus
Exhibits150: Novartis AG – Overview
Exhibits151: Novartis AG – Business segments
Exhibits152: Novartis AG – Key offerings
Exhibits153: Novartis AG – Segment focus
Exhibits154: Novo Nordisk AS – Overview
Exhibits155: Novo Nordisk AS – Business segments
Exhibits156: Novo Nordisk AS – Key offerings
Exhibits157: Novo Nordisk AS – Segment focus
Exhibits158: Prospec Tany Technogene Ltd. – Overview
Exhibits159: Prospec Tany Technogene Ltd. – Product / Service
Exhibits160: Prospec Tany Technogene Ltd. – Key offerings
Exhibits161: Proteintech Group Inc. – Overview
Exhibits162: Proteintech Group Inc. – Product / Service
Exhibits163: Proteintech Group Inc. – Key offerings
Exhibits164: Sanofi SA – Overview
Exhibits165: Sanofi SA – Business segments
Exhibits166: Sanofi SA – Key news
Exhibits167: Sanofi SA – Key offerings
Exhibits168: Sanofi SA – Segment focus
Exhibits169: Sino Biological Inc. – Overview
Exhibits170: Sino Biological Inc. – Product / Service
Exhibits171: Sino Biological Inc. – Key offerings
Exhibits172: Thermo Fisher Scientific Inc. – Overview
Exhibits173: Thermo Fisher Scientific Inc. – Business segments
Exhibits174: Thermo Fisher Scientific Inc. – Key news
Exhibits175: Thermo Fisher Scientific Inc. – Key offerings
Exhibits176: Thermo Fisher Scientific Inc. – Segment focus
Exhibits177: Inclusions checklist
Exhibits178: Exclusions checklist
Exhibits179: Currency conversion rates for US$
Exhibits180: Research methodology
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Information sources
Exhibits183: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 組換えタンパク質の世界市場2023年~2027年(Global Recombinant Proteins Market 2023-2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆